Physician

Dmitry Nemirovsky, M.D.

According to 2025 Medicare claims, Dmitry Nemirovsky, M.D. (NPI: 1518086933) practices cardiac electrophysiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is MEDICAL ASSOCIATES OF ENGLEWOOD, PC (NPI: 1952681918; TIN: 452548322) and primary practice location at 07601-1997. Nemirovsky is affiliated with the Englewood Health ACO, LLC (ACO ID: A5653), participating under the MSSP model.

Nemirovsky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,143 traditional Medicare patients, billed 4,144 HCPCS/CPT codes, and received $275,967 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 364 prescription claims across 124 beneficiaries totaling $125,751 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 23 claims. Open Payments data shows 46 records totaling $21,412. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $63,637 and ending at $125,751. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	994	3,212	$246,596
2016	898	2,845	$213,811
2017	797	2,913	$228,717
2018	930	3,201	$230,105
2019	917	3,103	$223,108
2020	656	2,744	$192,262
2021	814	3,272	$209,897
2022	886	3,536	$215,204
2023	1,195	3,920	$228,040
2024	1,143	4,144	$275,967

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	95	301	$63,637
2016	109	405	$108,976
2017	93	348	$346,255
2018	96	301	$92,447
2019	94	287	$77,885
2020	102	317	$160,588
2021	100	339	$157,930
2022	119	335	$211,504
2023	122	320	$171,900
2024	124	364	$125,751

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	23	$45,022
2016	N/R	22	$42,561
2017	N/R	23	$48,211
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	141	202	$112
93280	Programming of dual lead pacemaker system	129	182	$69
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	157	496	$24
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	223	370	$13
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	501	582	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	72	4,110	$79,222
Xarelto	Rivaroxaban	21	1,590	$27,061
Multaq	Dronedarone Hcl	12	360	$9,417
Amiodarone Hcl	Amiodarone Hcl	72	5,602	$2,938
Dofetilide	Dofetilide	11	797	$1,880

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$8,752	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$12,660	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dmitry Nemirovsky, M.D.?

Tedicare shows public-source Medicare data for Dmitry Nemirovsky, M.D. (NPI 1518086933), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dmitry Nemirovsky, M.D. have ACO affiliation data?

Dmitry Nemirovsky, M.D. is shown with ACO affiliation data for Englewood Health ACO, LLC (MSSP, ACO ID A5653).

What billing organization is linked to Dmitry Nemirovsky, M.D.?

Dmitry Nemirovsky, M.D. is linked to MEDICAL ASSOCIATES OF ENGLEWOOD, PC (billing NPI 1952681918) in the available physician profile data.

Does Dmitry Nemirovsky, M.D. have Open Payments data?

Dmitry Nemirovsky, M.D. has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.